OABIW
OmniAb, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.39
+0.98%Margins
Gross margin
50.5%
EBITDA margin
-66.3%
EBIT margin
-125.8%
Net margin
-115.2%
FCF margin
-47.2%
-17.0%
Return on equity
-15.2%
Return on assets
-17.3%
Return on invested capital
0.13x
Asset turnover
-$17.7M
Cash from operations
$0.46
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026